High prevalence of hyperlipidaemia in patients with AV re-entry tachycardia and AV nodal re-entry tachycardia

被引:0
作者
Ivan Zeljković
Kristijan Đula
Alen Babacanli
Ivan Kruljac
Vito Mustapić
Diana Delić Brkljačić
Nikola Bulj
Vjekoslav Radeljić
Šime Manola
Nikola Pavlović
机构
[1] Sestre milosrdnice University Hospital Centre,Department of Cardiology
[2] Sestre milosrdnice University Hospital Centre,Department of Emergency Medicine
[3] Sestre milosrdnice University Hospital Centre,Department of Internal Medicine
[4] University of Zagreb,School of Medicine
来源
Scientific Reports | / 9卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Diet rich in lipids and hyperlipidaemia increases incidence of atrial premature beats and all supraventricular arrhythmias. The aim of the study was to investigate the prevalence of hyperlipidaemia in patients with AV re-entry tachycardia (AVRT) and AV nodal re-entry tachycardia (AVNRT). We conducted a retrospective, cross-sectional, case-control study that included all consecutive patients for whom AVRT or AVNRT was confirmed during electrophysiology study. Age and gender-matched patients admitted to hospital or outpatient clinic for various reasons were randomly included and served as a control group. Hyperlipidaemia was defined according to 2016 European Society of Cardiology guidelines. A total of 1448 subjects were included: 725 patients with AVRT/AVNRT and 723 controls. AVRT/AVNRT patients had high hyperlipidaemia prevalence, which was significantly higher when compared to the control group (50.1 vs. 35.8%, p < 0.001). AVRT patients, with median age of 37.5 years, had hyperlipidaemia prevalence of 45.7%. In a multivariate analysis, hyperlipidaemia was independently associated with AVRT/AVNRT (OR 2.128, p < 0.001), both with AVNRT (OR 1.878, p < 0.001) and AVRT (OR 2.786, p < 0.001). Hypercholesterolemia was significantly more prevalent in patients with AVNRT and AVRT, while this was not the case for hypertriglyceridemia. There were no differences between the AVRT and AVNRT patients regarding hyperlipidaemia prevalence (51.9 vs. 45.7%, p = 0.801), even though AVRT patients were significantly younger (37.5 vs. 48.5, p < 0.001). In conclusion, this is the first study that investigated hyperlipidaemia prevalence in patients with AVRT or AVNRT. AVRT/AVNRT patients had higher prevalence of hyperlipidaemia and higher total and LDL cholesterol levels.
引用
收藏
相关论文
共 36 条
[1]  
Chugh SS(2014)Global burden of atrial fibrillation in developed and developing nations Glob Heart. 9 113-9
[2]  
Roth GA(2016)2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS Europace. 18 1609-78
[3]  
Gillum RF(1998)Paroxysmal supraventricular tachycardia in the general population J Am Coll Cardiol. 31 150-7
[4]  
Mensah GA(2016)2015 ACC/AHA/HRS Guideline for the Management of Adult Patients With Supraventricular Tachycardia: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society J Am Coll Cardiol. 67 1575-623
[5]  
Kirchhof P(2016)2015 Risk Factors Collaborators. Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015 Lancet. 388 1659-724
[6]  
Orejarena LA(2016)2016 ESC/EAS Guidelines for the Management of Dyslipidaemias Eur Heart J. 37 2999-3058
[7]  
Page RL(2015)Hyperlipidemia in early adulthood increases long-term risk of coronary heart disease Circulation. 131 451-8
[8]  
Catapano AL(2013)Sympathetic cardiac hyperinnervation and atrial autonomic imbalance in diet-induced obesity promote cardiac arrhythmias Am J Physiol Heart Circ Physiol. 305 H1530-7
[9]  
Navar-Boggan AM(2015)Effects of Statins on First and Recurrent Supraventricular Arrhythmias in Patients With Mild Heart Failure (from the Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy) Am J Cardiol. 116 1869-74
[10]  
McCully BH(2012)Omega-3 in antiarrhythmic therapy: pros position High Blood Press Cardiovasc Prev. 19 201-5